ProtoKinetix, Inc.

PKTX · OTC · SIC 2834: Pharmaceutical Preparations
133
SEC Filings

Business Summary

ProtoKinetix, Inc. is a research and development stage biotechnology company focused on Anti-Freeze Glycoproteins (AFGPs), trademarked as AAGPs (Anti-Aging Glycoproteins). The company sponsors scientific medical research on the AAGP molecule and is pursuing commercial validation in healthcare markets, including targeted health care solutions. For fiscal year 2024, the company incurred $99,625 in R&D expenses. ProtoKinetix was originally incorporated as RJV Network, Inc. in Nevada in 1999.

Next Earnings

Q2 FY2026 — expected 2026-07-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionPKTXdiscussed_in_filing Cybersecurity
topic_mentionPKTXdiscussed_in_filing Trusted Computing
topic_mentionPKTXdiscussed_in_filing Blockchain & Crypto
topic_mentionPKTXdiscussed_in_filing Capital Expenditure
topic_mentionPKTXdiscussed_in_filing Regulation
topic_mentionPKTXdiscussed_in_filing Healthcare & Bio
topic_mentionPKTXdiscussed_in_filing Sovereign & Government
topic_mentionPKTXdiscussed_in_filing Cybersecurity
topic_mentionPKTXdiscussed_in_filing Trusted Computing
topic_mentionPKTXdiscussed_in_filing Blockchain & Crypto
topic_mentionPKTXdiscussed_in_filing Capital Expenditure
topic_mentionPKTXdiscussed_in_filing Regulation
topic_mentionPKTXdiscussed_in_filing Healthcare & Bio
topic_mentionPKTXdiscussed_in_filing Sovereign & Government
topic_mentionPKTXdiscussed_in_filing Cybersecurity
topic_mentionPKTXdiscussed_in_filing Trusted Computing
topic_mentionPKTXdiscussed_in_filing Blockchain & Crypto
topic_mentionPKTXdiscussed_in_filing Capital Expenditure
topic_mentionPKTXdiscussed_in_filing Regulation
topic_mentionPKTXdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-03-282024-12-310001079973-25-000516EDGAR26K words
2024-03-202023-12-310001079973-24-000403EDGAR—
2023-03-172022-12-310001079973-23-000353EDGAR—
2022-03-102021-12-310001079973-22-000230EDGAR—
2021-03-052020-12-310001079973-21-000148EDGAR—
2020-02-192019-12-310001079973-20-000119EDGAR—
2019-03-122018-12-310001079973-19-000124EDGAR—
2018-03-092017-12-310001079973-18-000141EDGAR—
2017-02-212016-12-310001079973-17-000127EDGAR—
2016-03-302015-12-310001079973-16-000885EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001079973-25-001708EDGAR12K words
2025-08-132025-06-300001079973-25-001254EDGAR—
2025-05-152025-03-310001079973-25-000816EDGAR—
2024-11-122024-09-300001079973-24-001493EDGAR—
2024-07-302024-06-300001079973-24-001123EDGAR—
2024-05-152024-03-310001079973-24-000714EDGAR—
2023-10-182023-09-300001079973-23-001455EDGAR—
2023-07-142023-06-300001079973-23-000958EDGAR—
2023-05-022023-03-310001079973-23-000595EDGAR—
2022-10-312022-09-300001079973-22-001380EDGAR—
2022-07-292022-06-300001079973-22-000911EDGAR—
2022-05-102022-03-310001079973-22-000560EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-11-210001553350-25-000111EDGAR1K words
2025-11-170001079973-25-001778EDGAR—
2025-10-100001079973-25-001594EDGAR—
2023-02-010001079973-23-000152EDGAR—
2023-01-040001079973-23-000012EDGAR—
2022-12-130001079973-22-001546EDGAR—
2022-03-210001079973-22-000312EDGAR—
2022-02-140001079973-22-000154EDGAR—
2021-12-230001079973-21-001270EDGAR—
2020-06-180001079973-20-000515EDGAR—

133 total filings indexed. 101 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

biotechnology healthcare type-1-diabetes-treatment

Company Identity

CIK0001128189
TickerPKTX
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedNV
HeadquartersDalton, Ohio

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 532b7ed049b85765fa9ec1c7f27e275a97bcd3822d8721a64990ad9ce6bf6621
parent: 5a8d150a56f1357a8c8cea9a1c52cad0c862005ad38c11ae568fbf718cb06431
content hash: 88652a60a4c1f68a00ab02e32ab48dea43ead988442d6cc2aa76c367af63cb32
signed: 2026-04-13T04:46:54.963Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf